Pacira BioSciences's chart data is dated 2026-10-09. Recorded technical signals: 52-week high, MA aligned, Bollinger breakout, MACD bullish cross. There are 7 published signal records.
Pacira BioSciences last closed at $36.31 (-0.22%) on 2026-10-09. Signals today: 52-week high, MA aligned, Bollinger breakout, MACD bullish cross. Listed on Nasdaq. Trailing 12 months PER is 100.0×. Its overall grade ranks 191 of 736 stocks in Healthcare.
About this company
Pacira BioSciences last closed at $36.31 (-0.22%) on 2026-10-09. Signals today: 52-week high, MA aligned, Bollinger breakout, MACD bullish cross. Listed on Nasdaq.
Details →Reported results
Position in sector
Healthcare · Overall A- · 191/736
Valuation grade F
Related stocks
- Johnson & JohnsonCompetitor
수술 후 통증관리·마취/진통제 영역에서 경쟁
- PfizerCompetitor
제약사로서 비마약성 진통·병원용 치료제 시장에서 경쟁
- MerckCompetitor
병원 처방의약품 경쟁사로 통증·수술 관련 치료제 영역에서 비교 대상
About Pacira BioSciences
- What technical signals does Pacira BioSciences (PCRX) have?
- Pacira BioSciences current technical signals: MA alignment (score 0.70).
- Is Pacira BioSciences a cup-and-handle pattern?
- No. Pacira BioSciences has no valid Cup signal right now.
- What published figures are available for Pacira BioSciences?
- Market cap: $1.56B. Trailing 12 months PER: 100.0×. Latest quarter PBR: 2.18×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Major stocks in the same sector
2026-10-10 dataset
Turn what you saw on this name into a strategy
Ask Q about Pacira BioSciences, or open the plan table on the main site.
From the names you found to a trading rule
Tell Q about the stocks you found to place orders with your conditions.